A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity-Reference-Cited by-同舟云学术

A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity

Published:2018-04 Issue:16 Volume:293 Page:5909-5919
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Shi Sally Yu,Lu Ya-Wen,Liu Zhi,Stevens Jennitte,Murawsky Christopher M.,Wilson Vicki,Hu Zhonghua,Richards William G.,Michaels Mark Leo,Zhang Jun,Yan Wei,Li Yang

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference22 articles.

1. Alternative molecular formats and therapeutic applications for bispecific antibodies;Spiess;Mol. Immunol,2015

2. The making of bispecific antibodies;Brinkmann;MAbs,2017

3. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization;Ridgway;Protein Eng,1996

4. An efficient route to human bispecific IgG;Merchant;Nat. Biotechnol,1998

5. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site;Bostrom;Science,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biparatopic antibodies: therapeutic applications and prospects;mAbs;2024-03-04

2. i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists;Nature Communications;2024-01-20

3. Effects of Fc glycosylation on the activity of WNT mimetic agonistic antibodies;Antibody Therapeutics;2024-01

4. Identification of Mispairing Omic Signatures in Chinese Hamster Ovary (CHO) Cells Producing a Tri-Specific Antibody;Biomedicines;2023-10-25

5. Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies;Frontiers in Immunology;2023-10-24